Abstract
CIGARETTE SMOKING IS THE LOWER RISK OF PARKINSON DISEASE
Suresh Undati*, Madhuri Boompally, Saikumar Manneboina, Srikanth Kotari
ABSTRACT
Parkinson disease is the one of the most common neurologic disorder, affecting approximately 1% of individuals over than 60 years causing progressive disability that can be slowed, but not halted, by treatment. As a major component of tobacco smoke, nicotine has been proposed to be asubstance for preventing against Parkinson disease risk. With a key role in regulating straital activity and behaviours mediated through the dopiminergic system. Animal studies also showed that nicotine could modulate dopamine transmission and reduce levadopaenduced dysakinesias. However, previous clinical trials yield contaversial results regarding nicotine treatment. In this review, we updated epidemiological, preclinical and clinical data, and studies on nicotine from diet.
[Full Text Article] [Download Certificate]WJPLS CITATION
All | Since 2019 | |
Citation | 422 | 322 |
h-index | 9 | 7 |
i10-index | 4 | 2 |
INDEXING
NEWS & UPDATION
BEST ARTICLE AWARDS
World Journal of Pharmaceutical and life sciences is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.
Best Article of current issue
Download Article : Click here